TerrAscend (TSNDF) Total Debt (2020 - 2026)
TerrAscend's (TSNDF) quarterly Total Debt came in at $205.7 million in Q1 2026, up 10.27% year-on-year from $186.5 million in Q1 2025, and down 1.65% on a QoQ basis from $209.2 million in Q4 2025.
TerrAscend (TSNDF) Total Debt (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 7 years of Total Debt data on file, last reported at $205.7 million in Q1 2026.
- On a quarterly basis, Total Debt rose 10.27% year-over-year to $205.7 million in Q1 2026; TTM through Mar 2026 was $205.7 million, a 10.27% increase from a year earlier, with the FY2025 full-year figure at $209.2 million, up 9.96% from the prior year.
- Total Debt for Q1 2026 stood at $205.7 million, down from $209.2 million in the prior quarter.
- Over the last five years, Total Debt for TSNDF reached as high as $249.0 million in Q1 2023 and fell as low as $68.1 million in Q4 2023.
- Historically, Total Debt has averaged $196.9 million across 5 years, with a median of $199.7 million in 2025.
- Across the five-year window, Total Debt tumbled 54.93% in 2023 and soared 179.41% in 2024, its largest moves.
- Year by year, Total Debt stood at $151.0 million in 2022, then tumbled by 54.93% to $68.1 million in 2023, then surged by 179.41% to $190.2 million in 2024, then climbed by 9.96% to $209.2 million in 2025, then decreased by 1.65% to $205.7 million in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $205.7 million in Q1 2026, $209.2 million in Q4 2025, and $222.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 205.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 205.71 Mn |
| Dec 31, 2025 | 209.17 Mn |
| Sep 30, 2025 | 222.27 Mn |
| Jun 30, 2025 | 199.67 Mn |
| Mar 31, 2025 | 186.54 Mn |
| Dec 31, 2024 | 190.22 Mn |
| Sep 30, 2024 | 190.28 Mn |
| Jun 30, 2024 | 187.87 Mn |
| Mar 31, 2024 | 182.95 Mn |
| Dec 31, 2023 | 68.08 Mn |
| Sep 30, 2023 | 225.49 Mn |
| Jun 30, 2023 | 204.33 Mn |
| Mar 31, 2023 | 248.96 Mn |
| Dec 31, 2022 | 151.04 Mn |
| Sep 30, 2022 | 247.63 Mn |
| Jun 30, 2022 | 239.64 Mn |
| Mar 31, 2022 | 187.67 Mn |
| Dec 31, 2021 | 189.47 Mn |
| Dec 31, 2020 | 171.34 Mn |